Exploration of Sepsis-Associated Coagulopathy Severity and Pediatric Septic Shock Outcomes

Abstract

The objective of this study was to explore correlations between sepsis-associated coagulopathy (SAC) in pediatric septic shock and clinical outcomes. This was a retrospective cohort study of all children admitted to a single, academic pediatric intensive care unit with septic shock over 6 years. The prevalence of SAC was 93.5% with 61% being severe. Those with severe SAC were more likely to have a positive blood culture and have longer median duration of ventilation. All observed mortalities occurred in the severe SAC and indeterminate SAC groups. SAC is highly prevalent in pediatric septic shock and may predict important outcomes.

Keywords

septic shock - disseminated intravascular coagulation - PICU

Note

This study was presented as an oral abstract presentation at the 2018 Society of Critical Care Medicine Congress and published in electronic abstract form only following that meeting.

Publikationsverlauf

Eingereicht: 06. April 2020

Angenommen: 07. Mai 2020

Artikel online veröffentlicht:
26. Juni 2020

• References

• 1 Weiss SL, Fitzgerald JC, Pappachan J. et al; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191 (10) 1147-1157
• 2 Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013; 14 (07) 686-693
• 3 Ruth A, McCracken CE, Fortenberry JD, Hall M, Simon HK, Hebbar KB. Pediatric severe sepsis: current trends and outcomes from the Pediatric Health Information Systems database. Pediatr Crit Care Med 2014; 15 (09) 828-838
• 4 Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348 (16) 1546-1554
• 5 Dellinger RP, Levy MM, Rhodes A. et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (02) 580-637
• 6 Children's Hospital Association. Improving pediatric sepsis outcomes [internet webpage]. Washington, DC. c2015–2019. Available at: https://www.childrenshospitals.org/Newsroom/Newsletters/Improving-Pediatric-Sepsis-Outcomes. Accessed October 21, 2019
• 7 Rivers E, Nguyen B, Havstad S. et al; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345 (19) 1368-1377
• 8 Mouncey PR, Osborn TM, Power GS. et al; ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372 (14) 1301-1311
• 9 Peake SL, Delaney A, Bailey M. et al; ARISE Investigators; ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371 (16) 1496-1506
• 10 Yealy DM, Kellum JA, Huang DT. et al; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370 (18) 1683-1693
• 11 Rhodes A, Phillips G, Beale R. et al. The surviving sepsis campaign bundles and outcome: results from the international multicenter prevalence study on sepsis (the IMPreSS study). Intensive Care Med 2015; 41 (09) 1620-1628
• 12 Workman JK, Ames SG, Reeder RW. et al. Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes. Pediatr Crit Care Med 2016; 17 (10) e451-e458
• 13 Levy MM, Rhodes A, Phillips GS. et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015; 43 (01) 3-12
• 14 Akcan Arikan A, Williams EA, Graf JM, Kennedy CE, Patel B, Cruz AT. Resuscitation bundle in pediatric shock decreases acute kidney injury and improves outcomes. J Pediatr 2015; 167 (06) 1301-5.e1
• 15 Davis AL, Carcillo JA, Aneja RK. et al. American college of critical care medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2017; 45 (06) 1061-1093
• 16 Levi M, van der Poll T. Coagulation and sepsis. Thromb Res 2017; 149: 38-44
• 17 Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 2015; 28 (02) 227-236
• 18 Levi M. Disseminated intravascular coagulation. Crit Care Med 2007; 35 (09) 2191-2195
• 19 Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341 (08) 586-592
• 20 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
• 21 Gando S, Iba T, Eguchi Y. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34 (03) 625-631
• 22 Di Nisio M, Thachil J, Squizzato A. Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis. Thromb Res 2015; 136 (02) 239-242
• 23 Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med 2018; 46 (05) 736-742
• 24 Thomas NJ, Tamburro RF, Rajasekaran S, Fitzgerald JC, Weiss SL, Hall MW. Bacterial sepsis. In: Nichols DG, Shaffner DH. eds. Rogers' Textbook of Pediatric Intensive Care. 5th ed. Philadelphia, PA: Wolters Kluwer; 2016: 1377-1396
• 25 Oren H, Cingöz I, Duman M, Yilmaz S, Irken G. Disseminated intravascular coagulation in pediatric patients: clinical and laboratory features and prognostic factors influencing the survival. Pediatr Hematol Oncol 2005; 22 (08) 679-688
• 26 Rivera R, Tibballs J. Complications of endotracheal intubation and mechanical ventilation in infants and children. Crit Care Med 1992; 20 (02) 193-199
• 27 Colling ME, Bendapudi PK. Purpura fulminans: mechanism and management of dysregulated hemostasis. Transfus Med Rev 2018; 32 (02) 69-76
• 28 Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38 (Suppl. 02) S26-S34